Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
J Mycol Med ; 29(3): 260-264, 2019 Sep.
Article in English | MEDLINE | ID: mdl-31445820

ABSTRACT

Saksenaea vasiformis is an emerging human pathogen, belonging to the order Mucorales of the subphylum Mucormycotina, most often associated with rhino-cerebral, cutaneous and subcutaneous infections following trauma. A review of the published literature was attempted on the occasion of a cutaneous leg infection with favorable outcome in a young immunocompetent man after mild injury. The overall aim was the facilitation of the study and the integrated understanding of this kind of fungal infections.


Subject(s)
Immunocompetence , Leg Injuries/complications , Mucormycosis/diagnosis , Adult , Amphotericin B/therapeutic use , Antifungal Agents/therapeutic use , Debridement , Humans , Inflammation , Leg/microbiology , Leg/pathology , Leg Injuries/microbiology , Magnetic Resonance Imaging , Male , Mucorales/isolation & purification , Mucorales/pathogenicity , Mucormycosis/drug therapy , Mucormycosis/immunology
3.
Eur J Radiol ; 97: 101-109, 2017 Dec.
Article in English | MEDLINE | ID: mdl-29153359

ABSTRACT

Multi-detector computed tomography is today the workhorse in the evaluation of the vast majority of patients with known or suspected liver disease. Reasons for that include widespread availability, robustness and repeatability of the technique, time-efficient image acquisitions of large body volumes, high temporal and spatial resolution as well as multiple post-processing capabilities. However, as the technique employs ionizing radiation and intravenous iodine-based contrast media, the associated potential risks have to be taken into account. In this review article, liver protocols in clinical practice are discussed with emphasis on optimisation strategies. Furthermore, recent developments such as perfusion CT and dual-energy CT and their applications are presented.


Subject(s)
Liver Diseases/diagnostic imaging , Multidetector Computed Tomography/trends , Carcinoma, Hepatocellular/diagnostic imaging , Contrast Media , Humans , Liver Cirrhosis/diagnostic imaging , Multidetector Computed Tomography/methods , Radiography, Dual-Energy Scanned Projection/methods
4.
Eur Radiol ; 26(11): 4021-4029, 2016 Nov.
Article in English | MEDLINE | ID: mdl-26965503

ABSTRACT

OBJECTIVES: To compare a low-tube-voltage with or without high-iodine-load multidetector CT (MDCT) protocol with a normal-tube-voltage, normal-iodine-load (standard) protocol in patients with pancreatic ductal adenocarcinoma (PDAC) with respect to tumour conspicuity and image quality. METHODS: Thirty consecutive patients (mean age: 66 years, men/women: 14/16) preoperatively underwent triple-phase 64-channel MDCT examinations twice according to: (i) 120-kV standard protocol (PS; 0.75 g iodine (I)/kg body weight, n = 30) and (ii) 80-kV protocol A (PA; 0.75 g I/kg, n = 14) or protocol B (PB; 1 g I/kg, n = 16). Two independent readers evaluated tumour delineation and image quality blindly for all protocols. A third reader estimated the pancreas-to-tumour contrast-to-noise ratio (CNR). Statistical analysis was performed with the Chi-square test. RESULTS: Tumour delineation was significantly better in PB and PA compared with PS (P = 0.02). The evaluation of image quality was similar for the three protocols (all, P > 0.05). The highest CNR was observed with PB and was significantly better compared to PA (P = 0.02) and PS (P = 0.0002). CONCLUSION: In patients with PDAC, a low-tube-voltage, high-iodine-load protocol improves tumour delineation and CNR leading to higher tumour conspicuity compared to standard protocol MDCT. KEY POINTS: • Low-tube-voltage high-iodine-load MDCT improves pancreatic cancer conspicuity compared to a standard protocol. • The pancreas-to-tumour attenuation difference increases significantly by reducing the tube voltage. • The radiation exposure dose decreases by reducing the tube voltage.


Subject(s)
Carcinoma, Pancreatic Ductal/diagnostic imaging , Iopamidol/analogs & derivatives , Multidetector Computed Tomography/methods , Pancreatic Neoplasms/diagnostic imaging , Radiographic Image Enhancement/methods , Triiodobenzoic Acids/pharmacokinetics , Aged , Contrast Media/pharmacokinetics , Female , Humans , Iopamidol/pharmacokinetics , Male , Prospective Studies , Radiation Dosage , Radiographic Image Interpretation, Computer-Assisted/methods , Reproducibility of Results
5.
Br J Surg ; 103(3): 267-75, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26572509

ABSTRACT

BACKGROUND: Locoregional pancreatic ductal adenocarcinoma (PDAC) may progress rapidly and/or disseminate despite having an early stage at diagnostic imaging. A prolonged interval from imaging to resection might represent a risk factor for encountering tumour progression at laparotomy. The aim of this study was to determine the therapeutic window for timely surgical intervention. METHODS: This observational cohort study included patients with histologically confirmed PDAC scheduled for resection with curative intent from 2008 to 2014. The impact of imaging-to-resection/reassessment (IR) interval, vascular involvement and tumour size on local tumour progression or presence of metastases at reimaging or laparotomy was evaluated using univariable and multivariable regression. Risk estimates were approximated using hazard ratios (HRs). RESULTS: Median IR interval was 42 days. Of 349 patients scheduled for resection, 82 had unresectable disease (resectability rate 76.5 per cent). The unresectability rate was zero when the IR interval was 22 days or shorter, and was lower for an IR interval of 32 days or less compared with longer waiting times (13 versus 26.2 per cent; HR 0.42, P = 0.021). It was also lower for tumours smaller than 30 mm than for larger tumours (13.9 versus 32.5 per cent; HR 0.34, P < 0.001). Tumours with no or minor vascular involvement showed decreased rates of unresectable disease (20.6 per cent versus 38 per cent when there was major or combined vascular involvement; HR 0.43, P = 0.007). However, this failed to reach statistical significance on multivariable analysis (P = 0.411), in contrast to IR interval (P = 0.028) and tumour size (P < 0.001). CONCLUSION: Operation within 32 days of diagnostic imaging reduced the risk of tumour progression to unresectable disease by half compared with a longer waiting time. The results of this study highlight the importance of efficient clinical PDAC management.


Subject(s)
Carcinoma, Pancreatic Ductal/diagnosis , Diagnostic Imaging/methods , Pancreatectomy/methods , Pancreatic Neoplasms/diagnosis , Adult , Aged , Aged, 80 and over , Carcinoma, Pancreatic Ductal/surgery , Disease Progression , Female , Follow-Up Studies , Humans , Laparotomy , Male , Middle Aged , Pancreatic Neoplasms/surgery , Prognosis , Retrospective Studies , Time Factors
6.
Pancreatology ; 13(6): 570-5, 2013.
Article in English | MEDLINE | ID: mdl-24280571

ABSTRACT

BACKGROUND/OBJECTIVES: Ductal adenocarcinoma in the head of the pancreas (PDAC) is usually unresectable at the time of diagnosis due to the involvement of the peripancreatic vessels. Various preoperative classification algorithms have been developed to describe the relationship of the tumor to these vessels, but most of them lack a surgically based approach. We present a CT-based classification algorithm for PDAC based on surgical resectability principles with a focus on interobserver variability. METHODS: Thirty patients with PDAC undergoing pancreaticoduodenectomy were examined by using a standard CT protocol. Nine radiologists, representing three different levels of expertise, evaluated the CT examinations and the tumors were classified into four categories (A-D) according to the proposed system. For the interobserver agreement, the Intraclass Correlation Coefficient (ICC) was estimated. RESULTS: The overall ICC was 0.94 and the ICCs among the trainees, experienced radiologists, and experts were 0.85, 0.76, and 0.92, respectively. All tumors classified as category A1 showed no signs of vascular invasion at surgery. In category A2, 40% of the tumors had corresponding infiltration and required resection of the superior mesenteric vein/portal vein (SMV/PV). One of two tumors in category B2 and two of three in category C required SMV/PV resection. All six patients in category D had both arterial and venous involvement. CONCLUSION: There is almost perfect agreement among radiologists with different levels of expertise in regards to the local staging of PDAC. For tumors in a more advanced preoperative category, an increased risk for vascular involvement was noticed at surgery.


Subject(s)
Neoplasm Staging/methods , Pancreatic Neoplasms/diagnostic imaging , Tomography, X-Ray Computed/methods , Adult , Aged , Algorithms , Combined Modality Therapy , Contrast Media , Female , Humans , Image Processing, Computer-Assisted , Male , Middle Aged , Observer Variation , Pancreas/blood supply , Pancreas/pathology , Pancreatic Neoplasms/classification , Pancreatic Neoplasms/therapy , Pancreaticoduodenectomy/methods , Prognosis , Prospective Studies , Regional Blood Flow , Reproducibility of Results , Survival Analysis
SELECTION OF CITATIONS
SEARCH DETAIL